Pavan Cheruvu

Dr. Pavan K.
Cheruvu, MD, is a Chairman at Imbria Pharmaceuticals, Inc. and a Chief Executive Officer & Director at Amanat Acquisition Corp.
He is on the Board of Directors at Amanat Acquisition Corp.
Dr. Cheruvu was previously employed as a President, Chief Executive Officer & Director by Sio Gene Therapies, Inc., a Chief Executive Officer by Axovant Sciences, Inc., and a President, Chief Executive Officer & Director by Bitterroot Bio, Inc. He also served on the board at Retension Pharmaceuticals, Inc. He received his undergraduate degree from Duke University, a graduate degree from the University of Oxford and a doctorate degree from Harvard Medical School.